Skip to main content

Table 2 Transmission drug resistance among ART naïve HIV-1 infections from Guangdong China

From: Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study

Subtypes Number Number of TDR Prevalence (%) Prevalence (%)
PI NRTI NNRTI
CRF07_BC 850 10 1.18 0.12 (1/850) 0.82 (7/850) 0.24 (2/850)
CRF01_AE 842 24 2.85 0.71 (6/842) 0.95 (8/842) 1.31 (11/842)
CRF55_01B 244 5 2.05 0 1.64 (4/244) 0.41 (1/244)
Subtype B 70 3 4.29 1.43 (1/70) 0 2.86 (2/70)
CRF08_BC 66 2 3.03 0 1.52 (1/66) 1.52 (1/66)
CRF59_01B 53 1 1.89 0 (0/53) 1.89 (1/53)
Other 243 7 2.88 0 0.82 (2/243) 2.06 (5/243)
 Subtype C 11 2 18.18 0 0 18.18 (2/11)
 Subtype G 3 0 0 0 0 0
 CRF02_AG 3 0 0 0 0 0
 CRF12_BF 1 0 0 0 0 0
Recombinant strain 225 5 2.22 (0/225) 0.89 (2/225) 1.33 (3/225)
Total 2368 52 2.20 0.34 (8/2368) 0.93 (22/2368) 0.97 (23/2368)
  1. TDR, transmission drug resistance; PI, protease inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor